David Georges

Director of Finance/CFO presso CELYAD ONCOLOGY SA

Health Technology

Consumer Services

Profilo

David Georges is currently the Vice President-Finance & Administration at Celyad Oncology SA. Previously, he worked as the Director-Finance & Administration at DIAsource ImmunoAssays SA and as a Financial Manager at Merck KGaA.
Mr. Georges completed his undergraduate degree at Université Catholique de Louvain.

Posizioni attive di David Georges

Società	Posizione	Inizio
CELYAD ONCOLOGY SA	Director of Finance/CFO	01/01/2019

Tutte le posizioni attive di David Georges

Precedenti posizioni note di David Georges

Società	Posizione	Fine
MERCK KGAA	Corporate Officer/Principal	-
DIAsource ImmunoAssays SA DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium.	Director of Finance/CFO	-

Vedi nel dettaglio l'esperienza di David Georges

Formazione di David Georges

Université Catholique de Louvain

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Georges

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
MERCK KGAA	Health Technology
CELYAD ONCOLOGY SA	Health Technology

Aziende private	1
DIAsource ImmunoAssays SA DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium.	Health Technology